From the Professor..., page-23

Again about HER-Vaxx, the commercial application was also going to be used to make Chemotherapy more effective by causing less side effect so the actual Chemotherapy doesn't cause the mortality and the current Ph2 clinical trial data demonstrate very good efficacy and no toxicity at all. If you invested for HER-Vaxx then you should have known it was never going to replace Chemotherapy, there's still a market for this as not all cancer treatment current and in the future will response to the treatment and Chemotherapy will be the last resort.

Again why are you comparing different virus?? Is solid tumour in liver more difficult to treat than Bile duct and isn't the response from patient with cholangiocarcinoma 2 from 2 (CR who has been longest on very low dosage and SD who has been 200 days behind the CR also on very low dosage)? Also, it looks like Ph1 of Pexa-Vec started a decade ago and Ph3 clinical trial failed in 5 years ago? You don't think there has been scientific advancement over a decade ago?????